[D19-01] Biomarker-based tests to support the decision for or against adjuvant systemic chemotherapy in primary breast cancer - state of knowledge
|Commission:||Commission awarded on 2019-07-11 by the Federal Joint Committee (G-BA)|
|Current document:||Extract of the rapid report Further documents|
The rapid report was sent to the contracting agency (G-BA) on 18 February 2020 and published earlier than planned on 27 February 2020 at the request of the G-BA.
|Contact address:||to the contact form|